Bank Of New York Mellon Corp Dyadic International Inc Transaction History

Bank Of New York Mellon Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.25 - $1.86 $15,717 - $23,387	12,574 New	12,574 $22.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.18 - $2.32 $14,837 - $29,171	12,574 New	12,574 $15,000
Q1 2022 May 11, 2022	SELL	$3.01 - $4.81 $60,199 - $96,199	-20,000 Reduced 61.4%	12,574 $38,000
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.49 $14,272 - $28,069	-4,325 Reduced 11.72%	32,574 $181,000
Q2 2021 Aug 11, 2021	SELL	$3.35 - $5.67 $130,020 - $220,064	-38,812 Reduced 51.26%	36,899 $132,000
Q1 2021 May 13, 2021	SELL	$4.75 - $6.87 $1,757 - $2,541	-370 Reduced 0.49%	75,711 $415,000
Q4 2020 Feb 09, 2021	SELL	$5.35 - $7.77 $13,091 - $19,013	-2,447 Reduced 3.12%	76,081 $409,000
Q3 2020 Nov 12, 2020	BUY	$7.22 - $9.11 $1,205 - $1,521	167 Added 0.21%	78,528 $594,000
Q2 2020 Aug 12, 2020	BUY	$4.93 - $10.26 $219,286 - $456,364	44,480 Added 131.28%	78,361 $678,000
Q1 2020 May 06, 2020	BUY	$2.58 - $6.6 $34,489 - $88,228	13,368 Added 65.17%	33,881 $176,000
Q3 2019 Nov 07, 2019	BUY	$4.98 - $6.7 $102,154 - $137,437	20,513 New	20,513 $125,000

4.68M

11.4K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $31.3M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.